Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 11 min ago
Peer-reviewedCC BY-NC-NDSaudi Journal of Internal Medicine

Glucagon-like peptide-1 receptor agonists beyond weight loss: A paradigm shift in cardiovascular prevention

  • Alaa Solaiman Algazzar
Read full textDOICite

Related

  1. Glucagon-Like Peptide 1 Receptor Agonists, Mortality, and Cardiovascular Outcomes in Serious Mental Illness
    Roger S. McIntyre, Yanli Zhang-James, Angela T. H. Kwan
    JAMA PsychiatryPeer-reviewedLicence not statedFull text1 citedEndocrinology & metabolismPMC
  2. Cardiovascular Outcomes in Patients with Type 2 Diabetes and Heart Failure with Reduced Ejection using Glucagon-like Peptide-1 Receptor Agonists
    M. Al-Nusair, A. Maini, S. Khurana +1
    medRxivPreprintCC BYFull textCardiovascular medicinemedRxiv
  3. Glucagon‐Like Peptide‐1 Receptor Agonists and Incident Cardiovascular Events and Death in Treated Serious Mental Illness, Type 2 Diabetes, and Obesity
    Samuel B. Governor, David M. Dávila‐García, Eliut Rivera‐Segarra +7
    Journal of the American Heart AssociationPeer-reviewedCC BY-NC-NDEndocrinology & metabolismCrossref
  4. Divergent ocular safety profiles of glucagon-like peptide-1 receptor agonists: a pharmacological heterogeneity framework
    Huili Li, Shengke Peng, Daoxi Lei
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review
    Audrey Y. Chang, Farrah J. Mateen
    Annals of clinical and translational neurologyPeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{algazzar2026glucagonlike,
  title = {{Glucagon-like peptide-1 receptor agonists beyond weight loss: A paradigm shift in cardiovascular prevention}},
  author = {Alaa Solaiman Algazzar},
  journal = {Saudi Journal of Internal Medicine},
  year = {2026},
  month = sep,
  doi = {10.4103/sjim.sjim_12_26},
  url = {https://doi.org/10.4103/sjim.sjim_12_26},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Glucagon-like peptide-1 receptor agonists beyond weight loss: A paradigm shift in cardiovascular prevention
AU  - Alaa Solaiman Algazzar
PY  - 2026
DA  - 2026/09/01
JO  - Saudi Journal of Internal Medicine
DO  - 10.4103/sjim.sjim_12_26
UR  - https://doi.org/10.4103/sjim.sjim_12_26
SN  - 1658-5763
SN  - 1658-7367
ER  -